Latest Breaking News On - Luke miels - Page 3 : comparemela.com

GSK amends commercial deal with Scynexis as antifungal recall drags into 2024

GSK's revival 'will become clear to investors in 2024'

GSK’s revival ‘will become clear to investors in 2024’, says Big Pharma group’s commercial chief after copying methods used by rival companies

Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves

In recent statements to the Financial Times and The Sunday Times, GSK plc GSK Chief Commercial Officer Luke Miels revealed the company's intent to pursue…

Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves - Verona Pharma (NASDAQ:VRNA)

In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion (£1.6 billion) range over the upcoming six months, aiming to fortify its pipeline.

AstraZeneca in £1bn bet on China's biotech: Britain's biggest drugmaker agrees to buy Shanghai-based Gracell

The takeover - which is one of AstraZeneca s first outright acquisitions in China - represents a bold move by long-serving boss Pascal Soriot (pictured).